The Effect of Active External Rewarming on Rewarming Rate in Simulated Prehospital Accidental Hypothermia
1 other identifier
interventional
11
1 country
1
Brief Summary
In this study, we aim to compare the effect of active external rewarming to passive rewarming in healthy research participants on core temperature. The participants will be cooled to a core temperature of 35 degress C, the rewarmed using 2 different scenarios. Scenario 1 will be with passive rewarming, scenario 2 with active rewarming. Shivering will be pharmacologically inhibited using Buspirone and Meperidine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2024
CompletedFirst Posted
Study publicly available on registry
April 2, 2024
CompletedStudy Start
First participant enrolled
May 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 2, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 2, 2024
CompletedFebruary 27, 2025
February 1, 2025
5 days
March 26, 2024
February 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Core body temperature
Esophageal measurement
2 hour cooling phase, 1 hour rewarming phase
Study Arms (2)
Passive rewarming
PLACEBO COMPARATORWrapping of participants using a 3-layered model with a vapor barrier, insulating materials and an outer shell.
Active rewarming
ACTIVE COMPARATORSame as "Passive rewarming" but with an added external heat source
Interventions
Eligibility Criteria
You may not qualify if:
- Drugs: Concomitant use of sedatives, MAO-inhibitors, SSRI, ritonavir, cimetidine, chlorpromazine, phenytoin, erythromycin, itraconazole, platelet inhibitors, Apomorphine, alcohol (during the trial period) or other opioids or opioid antagonists (during the trial period). History of drug dependency.
- Recent head injury (last. 12 months), known increased ICP, seizures or epilepsy
- Other: Known reduced liver- or kidney function, reduced respiratory drive, known supraventricular tachycardia or prolonged QTc, hypertrophy of the prostate or urinary constriction, ongoing pregnancy or breastfeeding. Known acute glaucoma, myasthenia gravis. Previous abdominal surgery. History of cold injuries or frostbites.
- Planned MRI the next two days after ingestion of temperature capsule.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Haukeland University Hospital
Bergen, 5021, Norway
Related Publications (1)
Mydske S, Helland AM, Borasio N, Brattebo G, Osteras O, Wiggen O, Assmus J, Strapazzon G, Thomassen O. Effect of active external rewarming on esophageal temperature in simulated prehospital accidental hypothermia: a randomized crossover trial. Scand J Trauma Resusc Emerg Med. 2025 Dec 12. doi: 10.1186/s13049-025-01528-7. Online ahead of print.
PMID: 41388306DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2024
First Posted
April 2, 2024
Study Start
May 28, 2024
Primary Completion
June 2, 2024
Study Completion
June 2, 2024
Last Updated
February 27, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share